The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More

23Andme Holding Co. AC Immune S.A. Acadia Pharmaceutica Adaptimmune Ther ADR Alector Inc Aligos Therapeutics Inc Annovis Bio Inc Arbutus Biopharma Cp Astrazeneca Plc ADR Axcella Health Inc Biogen Idec Biohaven Ltd Biontech Se ADR Bone Biologics Corp Bristol-Myers Squibb Cardiovascular Syst Checkmate Pharmaceuticals Inc Chemocentryx Inc Clearside Biomedi Cohbar Inc Cortexyme Inc Corvus Pharma Com Dicerna Pharmaceutic Editas Medicine Enanta Pharmaceutica Epizyme Inc Eyepoint Pharmaceuticals Inc Fibrogen Inc CS Fulgent Genetics Inc Genmab A/S ADR Graybug Vision Inc Haemonetics Corp Immutep Ltd ADR Inhibrx Inc Inovio Pharma Invitae Corp Jazz Pharma Plc Kadmon Holdings Llc Ligand Pharm Lipocine Inc Lucid Diagnostics Inc Maravai Lifesciences Holdings Inc Cl A Merck & Co Mink Therapeutics Inc Mirati Therapeutics Nasdaq Biotechnology Ishares ETF Nektar Therapeutics Nevro Corp Nextcure Inc Ocuphire Pharma Inc Oncosec Medical Oncternal Therapeutics Inc Pfizer Protagonist Therapeutics Inc Reata Pharma Regenxbio Inc Renaissance International IPO ETF Replimune Group Inc Roche Holding AG Basel American Depositary Shares Shockwave Medical Inc Silk Road Medical Inc Sotera Health Company Transcontinental Realty Investors Vaccitech Plc ADR Vbi Vaccines Inc CS Vericel Corporation Viatris Inc Vir Biotechnology Inc